AI-enabled protein design company Profluent has leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be used to create molecules with the power to edit human DNA.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, developed more than a decade ago, allows scientists to modify DNA sequences within...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
CHICAGO – Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient's response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference & Exhibition.
But there are challenges to putting together an effective genomics program, said Jackie Rice, vice president for information technology and chief...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
Sema4 announced Tuesday the AI-backed genomic and clinical data company was laying off around 250 workers, about 13% of its workforce, as part of a larger restructuring.
Combined with earlier layoffs from the first half of the year, Sema4 said it has cut approximately 30% of the jobs from its legacy business.
Additionally, founder Eric Schadt is stepping down from his roles as president and...
Digital technologies have filtered into nearly every facet of medicine, from drug discovery all the way to consumer fitness. But digital health isn't the only relative newcomer that could disrupt the status quo in health. The precision genomics space is also growing in popularity and use.
What is precision genomics, and how will this space work with digital health?
Precision genomics medicine...
Remote patient-monitoring company Athelas scored $132 million across two funding rounds, earning the startup unicorn status with a valuation of $1.5 billion.
General Catalyst and Tribe Capital each led one of the financing rounds. Other participants include Sequoia Capital, YCombinator, Greenoaks, Human Capital and Initialized Capital.
Athelas' flagship product, the Athelas One, uses a finger...
insitro, an artificial intelligence drug discovery startup, has added a $400 million Series C round to its already impressive fundraising haul. The financing is set to close during the first full week of April, according to the company.
Canadian Pension Plan Investment Board led the raise, which also included a laundry list of participants. These names include: Andreessen Horowitz, funds and...
